Part III of a Trilogy on Alignment in Digital Health
The first two posts in this trilogy explored a persistent reality: innovation in digital health rarely stalls because of science. It stalls when alignment is missing.
This final post focuses on what changes when alignment holds.
Across digital health, progress depends on the ability of innovators, regulators, healthcare providers, and payers to move within a system that is far more complex than it is often described.
It is not one regulator.
It is multiple regulators, often within the same government, operating under different mandates:
- regulators for pharma and devices, each with distinct frameworks
- regulators shaping how healthcare providers can implement and use technology
- national and regional authorities, adding layers across states and countries, and
- ongoing obligations across the total product lifecycle, including post-market surveillance.
At the same time, execution is shaped by institutional guardrails; how hospitals, laboratories, and health systems can actually adopt and use innovation in practice.
This is where alignment is either built or lost.
Because no single actor owns this system. And no single pathway fits all.
Alignment does not emerge. It is architected, and orchestrated.
In practice, alignment only holds when someone steps forward to architect and orchestrate across these layers, not as a gatekeeper, but as an integrator.
Not to own every decision, but to ensure decisions connect.
At the same time, execution still depends on shared accountability, across innovators, regulators, healthcare providers, and payers.
Waiting for perfect ownership or sequencing only reinforces delay. No more chicken and egg.
When alignment is built early, something shifts:
- Evidence is generated with purpose, not duplicated across silos
- Regulatory engagement becomes proactive, not reactive
- Technology is introduced into workflows that can absorb it, not resist it
- Value translates beyond performance, into adoption and reimbursement
Without alignment, effort fragments. More data is generated, more iterations occur, but progress slows.
With alignment, effort compounds. Decisions reinforce each other. Execution follows insight.
Innovation will not be limited by what we can build. It will be limited by how well we align; across stakeholders, across systems, and across the full lifecycle.
When alignment holds, progress does not need to be forced. It moves.
But alignment is not cost neutral. The real operational, regulatory, and organizational costs – of both achieving alignment and ignoring it – are rarely articulated. In the next post, We will make those costs explicit.